The aim of this study is to estimate the diagnostic value of postcontrast susceptibility-weighted imaging (CESWI) in the assessment of intracranial brain neoplasm at 3 T MRI. Our results showed that the SWI can be performed after gadolinium injection without information loss or signal change and the CESWI clearly visualized the characteristics and the architecture of brain neoplasm. The CESWI can be a match to the CET1 with regard to the visibility of tumor margin and internal architecture in intracranial tumors without information loss or signal change.
This abstract and the presentation materials are available to members only; a login is required.